Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

AGM Statement

25 May 2006 07:04

Torex Retail PLC25 May 2006 25 May 2006 Torex Retail Plc AGM STATEMENT Torex Retail ("Torex Retail" or "the Group"), an international market leader inthe provision of innovative retail IT systems, will today hold its AnnualGeneral Meeting. Chris Moore, Chairman and Chief Executive, will make thefollowing statement on current trading: The Group has made a good start to the year enjoying sales success in all ourkey business areas and geographic markets. In addition to the ÂŁ30 million of newcontracts that we secured in the first quarter, the Group has continued to winsignificant contracts with new and existing customers including McDonald's,Boots, Liz Claiborne, BT, Tesco, Walmart-Asda and the Dutch Post Office. Particularly pleasing was a contract with The Picture People, a US portraitstudio chain with over 300 outlets nationwide. This was our first new businesswin for our Lucas EPoS product from a US headquartered retailer and was achievedwithin a year of the launch of this product into the US market. The system willstart roll out in July and will be a valuable reference site for further salesprogress in the US. Integration of 2005 acquisitions has continued to plan and we have now agreedformal employment plans with our employees in Germany. As a result, plans arenow being implemented to reduce the workforce by approximately 150 employees,with restructuring costs and subsequent annualised savings in line with theoriginal estimates previously communicated to the Stock Market. In April we completed the US$55 million acquisition of Savista, whichrepresented a major strategic step in the development of our Group and itsfurther penetration of the US market. Torex Retail is now the global EPoSsupplier to McDonalds and a market leader in the Quick Service Restaurantsector, the fastest growing part of the hospitality market. We see tremendousopportunities for this business going forward both from increased sales toMcDonalds and new business wins from other international QSR chains and alsothrough indirect channel sales. Trading for the first quarter was in line with our budget and the continuedlevel of order intake gives the Board confidence that the first six months of2006 will meet expectations. As in previous years, we expect trading activity toincrease in the second six months of 2006. Based on our current order book andsales pipeline, we are confident of achieving the full year forecastexpectations currently in the Stock Market. Chris Moore, Chairman and Chief Executive of Torex Retail, commented: "I am delighted with the progress we have made this year to date. The continuingprogramme of integrating our acquisitions is delivering bottom line savings andoperating efficiencies at the same time as we continue to target top linegrowth. Last year saw us become the leading provider of retail IT systems across Europeand we believe 2006 will see us make significant steps towards becoming aleading supplier to the North American market as well as further strengtheningour market position and brand on the global stage. The continuing delivery of the company strategy is both exciting and representsfurther consolidation of delivering shareholder value". - ends - For further information please contact: Torex RetailChris Moore, Chairman and Chief Executive +44 (0)870 300 6061 Citigate Dewe RogersonGinny Pulbrook, Executive Director +44 (0)20 7282 2945Seb Hoyle, Associate Director +44 (0)20 7282 2822 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Jun 20217:00 amRNSCompletion of phase 1 of new US facility expansion
23rd Jun 20216:08 pmRNSDirector/PDMR Shareholding
10th Jun 20214:17 pmRNSHolding(s) in Company
3rd Jun 20211:37 pmRNSResult of AGM
11th May 20217:00 amRNSDirector/PDMR Shareholding
10th May 202110:00 amRNSDirector/PDMR Shareholding
5th May 20217:00 amRNSGrant of share options
29th Apr 20214:11 pmRNSHolding(s) in Company
28th Apr 20217:00 amRNSFinal Results and Notice of AGM
20th Apr 20211:07 pmRNSHolding(s) in Company
20th Apr 202112:10 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSNotice of Results
13th Apr 20217:00 amRNSHolding(s) in Company
1st Apr 20214:40 pmRNSSecond Price Monitoring Extn
1st Apr 20214:36 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSInitial phase of US facility expansion complete
26th Feb 20217:00 amRNSDirectorate Change
19th Feb 20213:52 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSMove to Electronic Reporting
8th Feb 20217:00 amRNSTrading Update
5th Feb 20214:40 pmRNSSecond Price Monitoring Extn
5th Feb 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSAppointment of Chief Financial Officer
6th Jan 20213:58 pmRNSPDMR Dealings
5th Jan 20217:00 amRNSConfirmation of Board appointments
4th Jan 202111:26 amRNSHoldings in Company
24th Dec 202012:56 pmRNSIssue of Equity & Total Voting Rights Replacement
24th Dec 202011:15 amRNSHoldings in Company
23rd Dec 20209:51 amRNSIssue of Equity and Total Voting Rights
4th Dec 20207:00 amRNSBoard Changes
3rd Dec 20204:54 pmRNSHoldings in Company
2nd Dec 20207:00 amRNSFirst delivery of OrthoPure® XT
27th Nov 20209:09 amRNSHoldings in Company
26th Nov 20204:02 pmRNSHoldings in Company
17th Nov 20207:00 amRNSAppointment of CEO
6th Nov 20207:00 amRNSHoldings in Company
29th Oct 20207:00 amRNSHoldings in Company
29th Oct 20207:00 amRNSChange of Registered Office
26th Oct 20204:50 pmRNSHoldings in Company
7th Oct 20201:50 pmEQSHardman & Co Research: Tissue Regenix (TRX): Funded through to profitability
28th Sep 202012:24 pmRNSHoldings in Company
16th Sep 20207:42 amRNSHoldings in Company
15th Sep 20204:40 pmRNSSecond Price Monitoring Extn
15th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20205:33 pmRNSHoldings in Company
2nd Sep 20207:00 amRNSUnaudited Interim Results
27th Aug 20207:00 amRNSNotice of Interim Results & Investor Presentation
24th Aug 20207:00 amRNSUK distribution partner for OrthoPure® XT
18th Aug 202011:27 amRNSHoldings in Company
17th Aug 20207:00 amRNSRelocation of UK office and manufacturing facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.